Publications Office of the EU
National procurement PD-(L)1 inhibitor 2025 - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

National procurement PD-(L)1 inhibitor 2025 Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    27/08/2024
  • Deadline
    17/10/2024
  • Opening of tenders
    18/10/2024
  • Awarded
    04/12/2024
  • Today
    22/04/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
Yes
Buyer
Region Stockholm - Serviceförvaltningen
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: SE110 Stockholms län
Business sector (Main CPV)
33652000 Antineoplastic and immunomodulating agents
Total estimated contract value (excluding VAT)
2,800,000,000.00 SEK
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
FSN 2023-0262
Description

National procurement of PD-(L)1 inhibitors in 2025 within the framework of the Region's collaboration model for pharmaceuticals. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://tendsign.com/doc.aspx?MeFormsNoticeId=28524&GoTo=Tender
Tenders may be submitted
Electronic submission: required
https://tendsign.com/doc.aspx?MeFormsNoticeId=28524&GoTo=Tender
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
18/10/2024 00:00
Place of performance
SE Sverige
Any country
CPV code

33652000 - Antineoplastic and immunomodulating agents

Award method
Criterion:
Type: price
Description:
Weight (percentage, exact): 1
Estimated value
2,800,000,000.00 SEK
Final contracted value
Not available
Award of contract
Official name: Merck Sharp & Dohme (Sweden) Aktiebolag
Postal address:
Town: STOCKHOLM
Postal code: 10430
Country:
Official name: BeiGene Sweden AB
Postal address:
Town: STOCKHOLM
Postal code: 11330
Country:
Official name: AstraZeneca AB
Postal address:
Town: SÖDERTÄLJE
Postal code: 15185
Country:
Official name: Roche Aktiebolag
Postal address:
Town: SOLNA
Postal code: 17123
Country:
Official name: GlaxoSmithKline AB
Postal address:
Town: SOLNA
Postal code: 171 54
Country:
Official name: Bristol-Myers Squibb Aktiebolag
Postal address:
Town: SOLNA
Postal code: 17123
Country:
Official name: Regeneron Ireland DAC
Postal address:
Town: Dublin
Postal code: D02 HH27
Country:
Official name: Merck Aktiebolag
Postal address:
Town: SOLNA
Postal code: 16903
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.